December 5 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Thursday that the chairman of its board of directors - Ognyan Donev, and its majority owner - drug maker Sopharma [BUL:3JR], have both increased their stakes in the company.
Sopharma bought 1,000 Sopharma Trading shares, while Donev acquired 1,193 shares in the drug trader, Sopharma Trading said in two separate bourse filings.
Both Sopharma and Donev paid 5.75 levs ($3.26/2.94 euro) per share.
At the end of September, Sopharma held a 72.97% stake in Sopharma Trading, while Donev held directly a stake of under 5%.
Sopharma Trading shares closed at 5.75 levs on Thursday, unchanged from their previous closing price on the Bulgarian Stock Exchange. Sopharma shares also closed without change, at 3.45 levs.
(1 euro = 1.95583 levs)